The weight you have been carrying.
Set it down.

Standard GLP-1 medications (like semaglutide/Ozempic) activate one hormone receptor to reduce appetite and improve blood sugar. GLP-1/GIP medications (like tirzepatide/Mounjaro and Zepbound) activate two hormone receptors simultaneously — producing stronger appetite suppression and superior weight loss results. Clinical trials show GLP-1/GIP combination therapies achieve 20–22% body weight reduction vs. 10–15% with GLP-1 alone.

Most patients notice reduced appetite within the first 1–2 weeks. Meaningful weight loss typically begins at 4–8 weeks and continues steadily. In clinical trials, participants lost an average of 1–2 pounds per week during the active treatment phase. Individual results vary based on starting weight, adherence, and diet.

GLP-1 medications are most effective when combined with a reduced-calorie diet and regular physical activity — and the good news is that the medication makes this significantly easier by reducing appetite and cravings. Most patients find they naturally eat less and feel more motivated to move. Your provider will give you lifestyle guidance alongside your prescription.

Studies show that weight can return after stopping GLP-1 therapy if lifestyle changes have not been maintained. This is why Reclaimed emphasizes ongoing provider support and sustainable behavior change throughout treatment. Many patients transition to a maintenance dose rather than stopping abruptly.